IFNG Protein Market

Global IFNG Protein Market, Size, Share and Trends Analysis Report By Purity Type (above 90%, above 95%, and above 99%), By Application (Biopharmaceutical Companies, Hospitals, Bioscience Research Institutions and Others), Forecast Period 2021-2027
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2024967 | Category : Pharmaceuticals | Delivery Format: /

IFNG protein stands for Interferon Gamma which is also known as Immune Interferon or IFN-Gamma. It is a type of protein coding gene associated with the diseases including Immunodeficiency 69, and Hepatitis C virus. IFNG is a type-II interferon mainly secreted by T-cells and NK- cells of immune system, which play significant role in antiviral, antimicrobial, and antitumor responses by enhancing antigen presentation and activating effectors immune cells. As the protein is homodimer in nature, it binds to the interferon gamma receptor and triggers a cellular response to viral and microbial infections. 

The global IFNG protein market is projected to grow at a significant CAGR during the forecast period 2021-2027. The IFNG protein market is segmented by type and by application.

Depending on the purity type, the IFNG market is segmented as above 90%, above 95%, and above 99%, where above 99% segment is estimated to grow the market value with improved installation of this product among the countries and with increasing demand it will encourage the global IFNG Protein Market growth. Additionally, based on the application, the market is segmented into biopharmaceuticals companies, hospitals, and bioscience research institutions. In these end users area the IFNG Protien play a significant role by inducing various therapeutics effects when examined on animal models.This result in improved examination and frequent results of the research and allow the market to increase the commercialization of the product in bulk and this rise in demand of the product for research will impact the growth of market and anticipated to raise its global market value in forecast period.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- 

o By Purity type

o By Application

  • Competitive Landscape- Aviva Systems Biology Corporation, Atlas Antibodies, Abbexa Ltd., Abiocode, Boster Biological Technology, Biobyt, Bio-Rad, Bioss Antibodies, Biosensis, Biolegend, BioVision, BethylLaboratories, Epigentek, EnzoLifeSciences, Genetex, LifeSpan Biosciences, Novus Biologicals, Proteintech, Prosci, ProteoGenix, RandD systems, Rockland, St John’s Laboratory Ltd. Stemcell, Thermo Fisher Scientific, USBiological.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global IFNG Protein Market Report Segment

By Purity Type

o Above 90%

o Above 95%

o Above 99%

By Application

o Biopharmaceutical Companies

o Hospitals

o Bioresearch Institutions

o Others 

Global IFNG Protein Market Report Segment by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World